Marble Wealth LLC Makes New $2.28 Million Investment in Cardinal Health, Inc. $CAH

Marble Wealth LLC bought a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 11,109 shares of the company’s stock, valued at approximately $2,283,000.

Other large investors have also recently made changes to their positions in the company. Aventura Private Wealth LLC purchased a new stake in shares of Cardinal Health during the 4th quarter valued at $25,000. Jones Financial Companies Lllp increased its position in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the last quarter. JPL Wealth Management LLC purchased a new stake in shares of Cardinal Health during the 3rd quarter valued at $31,000. Turning Point Benefit Group Inc. purchased a new stake in shares of Cardinal Health during the 3rd quarter valued at $31,000. Finally, Cape Investment Advisory Inc. increased its position in shares of Cardinal Health by 61.1% during the 3rd quarter. Cape Investment Advisory Inc. now owns 211 shares of the company’s stock valued at $33,000 after purchasing an additional 80 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

CAH stock opened at $194.96 on Wednesday. The company has a market capitalization of $45.66 billion, a price-to-earnings ratio of 29.81, a PEG ratio of 1.16 and a beta of 0.52. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60. The stock has a fifty day moving average of $203.21 and a 200-day moving average of $208.75.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.38. The company had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is currently 31.19%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. William Blair assumed coverage on Cardinal Health in a research report on Tuesday, April 28th. They set an “outperform” rating for the company. Leerink Partners reaffirmed an “outperform” rating and set a $275.00 target price on shares of Cardinal Health in a research report on Monday, March 9th. UBS Group set a $260.00 target price on Cardinal Health and gave the company a “buy” rating in a research report on Friday, February 6th. TD Cowen raised their target price on Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a research report on Friday, May 1st. Finally, Mizuho increased their price target on Cardinal Health from $222.00 to $235.00 and gave the stock an “outperform” rating in a research note on Friday, February 6th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and an average target price of $241.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.